Review Article
Adenosine-mediated Bronchoconstriction and Lung Inflammation in an Allergic Mouse Model

https://doi.org/10.1006/pupt.2001.0329Get rights and content

Abstract

In this study, we studied the role of adenosine on airway responsiveness and airway inflammation using an allergic mouse model. Mice were sensitized by two i.p. injections of ragweed and three consecutive ragweed aerosol challenges. It was found that inhalation of adenosine causes a dose-related bronchoconstriction in this model. Ragweed sensitized and challenged mice showed increased sensitivity to airway challenge to adenosine compared to control animals. Theophylline, a non-selective adenosine receptor antagonist, blocked adenosine-induced bronchoconstriction, but was unable to inhibit bronchoconstrictor response to methacholine. Mice systemically sensitized and airway challenged with allergen showed a marked airway inflammation manifesting increases in eosinophils, lymphocytes and neutrophils, and decrease in macrophages. Twenty-four hours after airway challenge with allergen, aerosolization of adenosine further potentiated the allergen-induced airway inflammation. Cells in bronchoalveolar lavage fluid after adenosine aerosolization increased by 3.07-fold as compared to control mice, and by 1.8-fold compared to ragweed sensitized and challenged mice. The increases in eosinophils, lymphocytes, and neutrophils caused by allergen were potentiated after adenosine challenge. Unexpectedly, macrophages significantly decreased after adenosine challenge. Theophylline attenuated adenosine-enhanced airway inflammation, but could not reverse allergen-induced airway inflammation. These findings suggested that specific adenosine receptors contribute to airway responsiveness and airway inflammation associated with this model of allergic asthma.

References (38)

  • JW Nyce et al.

    DNA antisense therapy for asthma in an animal model

    Nature

    (1997)
  • KA Overholser et al.

    Effect of exogenous adenosine on resistance, capillary permeability-surface area and flow in ischemic canine myocardium

    J Pharmacol Exp Ther

    (1984)
  • A Sollevi et al.

    Role of adenosine in adipose tissue circulation

    Acta Physiol Scand

    (1981)
  • J Tamaoki et al.

    Effect of cromolyn on adenosine-induced airway microvascular leakage in sensitized rats

    Eur Respir J

    (1999)
  • PT Peachell et al.

    Differential regulation of human basophil and lung mast cell function by adenosine

    J Pharmacol Exp Ther

    (1991)
  • BAM Walker

    Effects of adenosine on guinea pig pulmonary eosinophils

    Inflamm

    (1996)
  • AG Driver et al.

    Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma

    Am Rev Respir Dis

    (1991)
  • FR Rose et al.

    Adenosine promotes neutrophil chemotaxis

    J Exp Med

    (1988)
  • HG Johnson et al.

    Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives

    Br J Pharmacol

    (1985)
  • Cited by (40)

    • Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A<inf>1</inf> receptor

      2012, European Journal of Pharmacology
      Citation Excerpt :

      Results obtained from the functional studies showed that challenge of actively sensitized rats with aerosolized ovalbumin induced bronchial hyperreactivity, evidenced by an increased bronchoconstriction in response to all spasmogens used, that was not observed when sensitized rats were challenged with aerosolized saline. This finding is in accordance with previous experimental works performed on Brown Norway rats (Hannon et al., 2001) and on allergic mice (Fan and Mustafa, 2002) and demonstrates that, in Wistar rats, sensitization per sè does not cause bronchial hyperreactivity but allergen challenge is required to establish bronchial hyperreactivity, an important feature of allergic asthma. It is worth noting that this finding is also consistent with clinical observations about asthma; in fact, it must be considered that asthmatics undergo regular exposure to allergen.

    • Adenosine receptors and vascular inflammation

      2011, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      ADA deficient mice demonstrate the presence of eosinophilia in the lungs, extensive mast cell degranulation and increased levels of serum IgE [23], indicating a strong correlation between chronic elevation of adenosine levels and increased lung inflammation. There is evidence that adenosine causes recruitment of inflammatory cells to the lung [24] and amplification of the inflammatory response [25]. In allergic mice, adenosine, among other inflammatory mediators from allergic lung and activated leukocytes, is released [16,26].

    • Airway hyperresponsiveness to adenosine 5'-monophosphate in feline chronic inflammatory lower airway disease

      2011, Veterinary Journal
      Citation Excerpt :

      Cushley et al. (1983) first reported a concentration-dependent bronchoconstriction after inhalation of adenosine in asthmatic humans, but not in healthy volunteers. Similarly, in other species such as mice (Fan and Mustafa, 2002), Brown Norway rats (Hannon et al., 2001), guinea pigs (Thorne and Broadley, 1994) and rabbits (Ali et al., 1994), adenosine caused no or very weak bronchoconstrictor responses in healthy subjects. Adenosine’s ester AMP is as effective and much more water soluble (Mann et al., 1986).

    • Increased muscarinic receptor activity of airway smooth muscle isolated from a mouse model of allergic asthma

      2010, Pulmonary Pharmacology and Therapeutics
      Citation Excerpt :

      Adenosine also failed to produce a contractile response in trachea from O/V mice, i.e. sensitised but not OVA-challenged. This was surprising since sensitised and naive mice [15,43], sensitised guinea-pigs [44] and asthmatic patients [45] produce bronchoconstriction to NECA and adenosine in vivo. Passive or active sensitisation therefore favours a bronchoconstrictor response to adenosine in isolated trachea from guinea-pigs [46] but not mice.

    • Regadenoson: A New Myocardial Stress Agent

      2009, Journal of the American College of Cardiology
      Citation Excerpt :

      Trochu et al. (17) further showed in an animal model the lack of A1response in contradistinction to a dose-dependent A2Aresponse. Regadenoson was also shown to have absent bronchoconstrictive response in control and allergen-sensitized mice (18). By design, regadenoson has a low affinity for the A2Aadenosine receptor.

    View all citing articles on Scopus
    f1

    Author for correspondence: S. Jamal Mustafa, Ph.D., Department of Pharmacology, Brody school of Medicine, East Carolina University, Greenville, NC 27858, USA. Tel: (252) 816–2736; Fax: (252) 816–3203; E-mail:[email protected]

    View full text